Esophageal adenocarcinoma is a type of cancer that affects the esophagus, the tube connecting the throat to the stomach. It is the most common type of esophageal cancer in the United States. Esophageal adenocarcinoma usually begins in the cells that line the inside of the esophagus. It is often caused by damage to the cells due to chronic acid reflux, in which stomach acid flows backward into the esophagus. Other risk factors for esophageal adenocarcinoma include obesity, smoking, and alcohol consumption. Symptoms of esophageal adenocarcinoma may include difficulty swallowing, pain in the chest or throat, and weight loss. Diagnosis is typically done through endoscopy, in which a doctor inserts a thin tube with a camera into the esophagus to look for cancerous cells. Blood tests, imaging tests, and biopsy may also be used to diagnose the cancer. Treatment for esophageal adenocarcinoma typically involves surgery to remove the tumor, as well as chemotherapy and radiation therapy. The prognosis for esophageal adenocarcinoma depends on the stage of the cancer and the patient’s overall health. Early detection and treatment are important for improving the chance of a successful outcome. Esophageal adenocarcinoma can be a difficult cancer to diagnose and treat, but there are many options available to those who are diagnosed. By understanding the risk factors, recognizing the symptoms, and getting regular check-ups, people can help to reduce their risk of developing esophageal adenocarcinoma.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China